Related references
Note: Only part of the references are listed.MITOGEN AND STRESS-ACTIVATED KINASES 1/2 REGULATE ISCHEMIA-INDUCED HIPPOCAMPAL PROGENITOR CELL PROLIFERATION AND NEUROGENESIS
K. Karelina et al.
NEUROSCIENCE (2015)
Mammalian target of rapamycin is essential for cardiomyocyte survival and heart development in mice
Pengpeng Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Mammalian Target of Rapamycin Complex 2 ( mTORC2) Coordinates Pulmonary Artery Smooth Muscle Cell Metabolism, Proliferation, and Survival in Pulmonary Arterial Hypertension
Dmitry A. Goncharov et al.
CIRCULATION (2014)
Increased Pericyte Coverage Mediated by-Endothelial-Derived Fibroblast Growth Factor-2 and Interleukin-6 Is a Source of Smooth Muscle-Like Cells in Pulmonary Hypertension
Nicolas Ricard et al.
CIRCULATION (2014)
Inhibition of NOX/VPO1 Pathway and Inflammatory Reaction by Trimethoxystilbene in Prevention of Cardiovascular Remodeling in Hypoxia-induced Pulmonary Hypertensive Rats
Bin Liu et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2014)
mTORC1 Is Involved in Hypoxia-Induced Pulmonary Hypertension Through the Activation of Notch3
Wang Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/β-catenin signaling in human hepatocellular carcinoma
Xian-Cheng Zeng et al.
MOLECULAR CANCER (2014)
Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression
Maimon E. Hubbi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
TGF-β/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A
X. Shi et al.
CELL DEATH & DISEASE (2014)
Regulatory effects of a Mnk2-eIF4E feedback loop during mTORC1 targeting of human medulloblastoma cells
Frank Eckerdt et al.
ONCOTARGET (2014)
Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells
Jun Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2013)
Rapamycin Reverses Pulmonary Artery Smooth Muscle Cell Proliferation in Pulmonary Hypertension
Amal Houssaini et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
PKR regulates proliferation, differentiation, and survival of murine hematopoietic stem/progenitor cells
Xiangfei Liu et al.
BLOOD (2013)
mTOR and vascular remodeling in lung diseases: current challenges and therapeutic prospects
Elena A. Goncharova
FASEB JOURNAL (2013)
Thrombin-mediated activation of Akt signaling contributes to pulmonary vascular remodeling in pulmonary hypertension
Aiko Ogawa et al.
PHYSIOLOGICAL REPORTS (2013)
The RAX/PACT-PKR stress response pathway promotes p53 sumoylation and activation leading to G1 arrest
Richard L. Bennett et al.
CELL CYCLE (2012)
mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia
Vera P. Krymskaya et al.
FASEB JOURNAL (2011)
Vascular remodeling in pulmonary arterial hypertension: Multiple cancer-like pathways and possible treatment modalities
Seiichiro Sakao et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
mTORC2 Is Required for Proliferation and Survival of TSC2-Null Cells
Elena A. Goncharova et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Combinatorial Effects of Lapatinib and Rapamycin in Triple-Negative Breast Cancer Cells
Tongrui Liu et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia
C. Evangelisti et al.
LEUKEMIA (2011)
Role of Epidermal Growth Factor Inhibition in Experimental Pulmonary Hypertension
Bhola Kumar Dahal et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Rapamycin Regulates Endothelial Cell Migration through Regulation of the Cyclin-dependent Kinase Inhibitor p27Kip1
Stephanie C. Moss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Regulation of G(1) Arrest and Apoptosis in Hypoxia by PERK and GCN2-Mediated eIF2 alpha Phosphorylation
Yan Liu et al.
NEOPLASIA (2010)
Inhibition of mTOR attenuates store-operated Ca2+ entry in cells from endarterectomized tissues of patients with chronic thromboembolic pulmonary hypertension
Aiko Ogawa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Cellular and Molecular Basis of Pulmonary Arterial Hypertension
Nicholas W. Morrell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Suppression of c-Cbl tyrosine phosphorylation inhibits neointimal formation in balloon-injured rat arteries
Zhihui Tang et al.
CIRCULATION (2008)
Pathogenic mechanisms of pulmonary arterial hypertension
Stephen Y. Chan et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension
Fares A. Masri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice
Renate Paddenberg et al.
RESPIRATORY RESEARCH (2007)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
mTOR-dependent stimulation of the association of eIF4G and eIF3 by insulin
Thurl E. Harris et al.
EMBO JOURNAL (2006)
Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR) -dependent signaling
R Humar et al.
FASEB JOURNAL (2002)